{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T12:06:05Z","timestamp":1717675565741},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ijantimicag.2010.04.007","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T08:42:57Z","timestamp":1275986577000},"page":"230-233","source":"Crossref","is-referenced-by-count":2,"title":["Antimicrobial activity of DW286 against Streptococcus pneumoniae"],"prefix":"10.1016","volume":"36","author":[{"given":"Hee Soo","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Ji","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Rack","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hwan","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2010.04.007_bib1","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia","volume":"333","author":"Bartlett","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib2","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/AAC.48.6.2101-2107.2004","article-title":"High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study)","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib3","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/340400","article-title":"Resistance among Streptococcus pneumoniae: implications for drug selection","volume":"34","author":"Appelbaum","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib4","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJM199911113412013","article-title":"Fluoroquinolone-resistance in Streptococcus pneumoniae","volume":"341","author":"Li\u00f1ares","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/13543784.8.2.181","article-title":"Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial","volume":"8","author":"MacGowan","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/378809","article-title":"Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones","volume":"37","author":"Saravolatz","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib8","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/AAC.46.9.3071-3074.2002","article-title":"In vitro and in vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic","volume":"46","author":"Yun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jac\/dkg162","article-title":"In vitro development of resistance to a novel fluoroquinolone, DW286, in methicillin-resistant Staphylococcus aureus clinical isolates","volume":"51","author":"Kim","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijantimicag.2004.11.013","article-title":"Increased antibacterial activity of DW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and topoisomerase IV","volume":"25","author":"Yun","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib11","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005."},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib12","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/AAC.42.8.2032","article-title":"Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae","volume":"42","author":"Brenwald","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib14","series-title":"Statistics in bioassay","author":"Bliss","year":"1985"},{"key":"10.1016\/j.ijantimicag.2010.04.007_bib15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jac\/dkf024","article-title":"Role of newer fluoroquinolones in lower respiratory tract infections","volume":"49","author":"Lode","year":"2002","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910001950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857910001950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T22:30:09Z","timestamp":1559169009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857910001950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0924857910001950"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.04.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}